Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis. July 23, 2018 10:08 am by IWB Authorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading. We are primarily funded by readers. Please subscribe and donate to support us! Views:
